Veradigm | MDRX - Ativos





Ativos Alterar Data
Alcidion AUD 118.08M 2.46M 2025-12
Ambu A/S DKK 7.78B 169M 2026-06
Amplifon EUR 3.6B 328.33M 2026-06
Cardinal Health USD 57.3B 610M 2026-06
Centene USD 83.01B 1.84B 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Cigna USD 157.08B 3.82B 2026-06
Coloplast 48.8B 429M 2025-12
Convatec Group USD 3.52B 109.3M 2024-12
CVS Health USD 253.77B 794M 2026-06
Diasorin EUR 2.87B 257.21M 2025-06
Elevance Health USD 126.44B 611M 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Gulf Medical Proj AED 1.55B 700K 2026-03
Humana USD 57.2B 1.92B 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Maximus USD 4.37B 127.6M 2026-06
McKesson USD 88.33B 6.01B 2026-06
Med Life RON 3.34B 76.39M 2026-03
Molina Healthcare USD 16B 388M 2026-06
Omnicell USD 2B 5.25M 2026-06
Oriola-kd EUR 796.5M 149.6M 2026-03
Owens Minor USD 2.11B 308.57M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Rede D'or Sao Luiz BRL 113.23B 3.46B 2026-06
Siemens Healthineers EUR 45.74B 931M 2026-06
Sonova Holding CHF 5.92B 468.2M 2025-06
Supermax Corporation Bhd MYR 4.13B 37.88M 2026-03
UnitedHealth USD 309.73B 2.92B 2026-06
Veeva Systems USD 9.06B 69.33M 2026-06
Veradigm USD 1.5B 185.94M 2022-12
Xerox USD 9.72B 178M 2026-06